PWE-076 Dendritic Cell Characteristics in Pouchitis
نویسندگان
چکیده
منابع مشابه
RFC 4816 PWE 3 ATM Transparent Cell
This transparent cell transport service allows migration of ATM services to a PSN without having to provision the ATM subscriber or customer edge (CE) devices. The ATM CEs will view the ATM transparent cell transport service as if they were directly connected via a Time Division Multiplexer (TDM) leased line. This service is most likely to be used as an internal function in an ATM service provi...
متن کاملPWE 3 ATM Transparent Cell Transport
This transparent cell transport service allows migration of ATM services to a PSN without having to provision the ATM subscriber or customer edge (CE) devices. The ATM CEs will view the ATM transparent cell transport service as if they were directly connected via a Time Division Multiplexer (TDM) leased line. This service is most likely to be used as an internal function in an ATM service provi...
متن کاملComparison of Several Maturation Inducing Factors in Dendritic Cell Differentiation
Background: Dendritic cells (DCs) are professional antigen presenting cells that have an important role in the initiation of immune response. The use of maturation factors in dendritic cell differentiation provides a promising approach in immunotherapy. Objective: In this study, we compared tumor necrosis factor-α, polyribocytidylic acid, lipopolysacharide and CpG oligonucleotides in inducing d...
متن کاملDendritic Cell Immunotherapy, the Next Step in Cancer Treatment
Cancer immunotherapy has gained a lot of interest over the past few years due to the success of immune checkpoint inhibitors in treating cancer (1, 2). Immune checkpoint inhibitors, such as monoclonal antibodies against cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1), have been shown to increase survival of patients with advanced cancers (1, 2). These in...
متن کاملDendritic Cell Immunotherapy, the Next Step in Cancer Treatment
Cancer immunotherapy has gained a lot of interest over the past few years due to the success of immune checkpoint inhibitors in treating cancer (1, 2). Immune checkpoint inhibitors, such as monoclonal antibodies against cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1), have been shown to increase survival of patients with advanced cancers (1, 2). These in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gut
سال: 2013
ISSN: 0017-5749,1468-3288
DOI: 10.1136/gutjnl-2013-304907.365